CITY-PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CITY-PHARMA
Largest movements
- Tangible fixed assets -€31,787
down €31,787 (-31.3%), from €101,454 to €69,667
of which Other tangible fixed assets: -€18,066
- Receivables within one year -€24,463
down €24,463 (-23.1%), from €105,834 to €81,371
of which Trade receivables: -€19,640
- Intangible fixed assets -€15,000
down €15,000 (-11.3%), from €132,893 to €117,893
- Cash +€5,628
up €5,628 (+17.3%), from €32,616 to €38,244
mainly Depreciation (+€46,787) and Other debts (+€36,011)
- Profit (loss) carried forward -€112,104
down €112,104 (-77.7%), from -€144,318 to -€256,422
- Other debts +€36,011
up €36,011 (+11.6%), from €309,327 to €345,338
- Debts after one year -€31,068
down €31,068 (-18.4%), from €168,497 to €137,429
- Trade debts +€25,018
up €25,018 (+21.2%), from €117,960 to €142,978
- Current portion of long-term debt +€10,179
up €10,179 (+36.4%), from €27,967 to €38,146
- Gross operating margin -€44,523
down €44,523 (-24.4%), from €182,390 to €137,866
- Depreciation +€16,560
up €16,560 (+54.8%), from €30,226 to €46,787
- Staff costs +€6,983
up €6,983 (+3.9%), from €178,547 to €185,531
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €547,817 | €478,952 | -€68,865 | -12.6% |
| Fixed assets | 21/28 | €234,347 | €187,561 | -€46,787 | -20.0% |
| Intangible fixed assets | 21 | €132,893 | €117,893 | -€15,000 | -11.3% |
| Tangible fixed assets | 22/27 | €101,454 | €69,667 | -€31,787 | -31.3% |
| Plant, machinery and equipment | 23 | €15,895 | €9,461 | -€6,434 | -40.5% |
| Leasing and similar rights | 25 | €29,146 | €21,859 | -€7,286 | -25.0% |
| Other tangible fixed assets | 26 | €56,413 | €38,347 | -€18,066 | -32.0% |
| Current assets | 29/58 | €313,470 | €291,391 | -€22,078 | -7.0% |
| Stocks and contracts in progress | 3 | €151,464 | €147,812 | -€3,651 | -2.4% |
| Stocks | 30/36 | €151,464 | €147,812 | -€3,651 | -2.4% |
| Amounts receivable within one year | 40/41 | €105,834 | €81,371 | -€24,463 | -23.1% |
| Trade receivables | 40 | €101,010 | €81,371 | -€19,640 | -19.4% |
| Other amounts receivable | 41 | €4,824 | €0 | -€4,824 | -100% |
| Cash at bank and in hand | 54/58 | €32,616 | €38,244 | +€5,628 | +17.3% |
| Deferred charges and accrued income | 490/1 | €23,556 | €23,964 | +€408 | +1.7% |
| Total equity and liabilities | 10/49 | €547,817 | €478,952 | -€68,865 | -12.6% |
| Equity | 10/15 | -€125,718 | -€237,822 | -€112,104 | -89.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€144,318 | -€256,422 | -€112,104 | -77.7% |
| Amounts payable | 17/49 | €673,536 | €716,774 | +€43,239 | +6.4% |
| Amounts payable after more than one year | 17 | €168,497 | €137,429 | -€31,068 | -18.4% |
| Financial debts | 170/4 | €168,497 | €137,429 | -€31,068 | -18.4% |
| Amounts payable within one year | 42/48 | €479,498 | €551,046 | +€71,549 | +14.9% |
| Current portion of amounts payable after more than one year | 42 | €27,967 | €38,146 | +€10,179 | +36.4% |
| Trade debts | 44 | €117,960 | €142,978 | +€25,018 | +21.2% |
| Suppliers | 440/4 | €117,960 | €142,978 | +€25,018 | +21.2% |
| Advances received on contracts in progress | 46 | €6,234 | €67 | -€6,167 | -98.9% |
| Taxes, remuneration and social security | 45 | €18,010 | €24,517 | +€6,508 | +36.1% |
| Taxes | 450/3 | €0 | €2,078 | +€2,078 | |
| Remuneration and social security | 454/9 | €18,010 | €22,439 | +€4,429 | +24.6% |
| Other amounts payable | 47/48 | €309,327 | €345,338 | +€36,011 | +11.6% |
| Accrued charges and deferred income | 492/3 | €25,541 | €28,299 | +€2,758 | +10.8% |
| Remuneration, social security and pensions | 62 | €178,547 | €185,531 | +€6,983 | +3.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €30,226 | €46,787 | +€16,560 | +54.8% |
| Other operating charges | 640/8 | €418 | €320 | -€98 | -23.4% |
| Gross operating margin | 9900 | €182,390 | €137,866 | -€44,523 | -24.4% |
| Operating profit (loss) | 9901 | -€26,802 | -€94,771 | -€67,969 | -254% |
| Financial income | 75/76B | €2,077 | €3,104 | +€1,027 | +49.4% |
| Recurring financial income | 75 | €2,077 | €3,104 | +€1,027 | +49.4% |
| Financial charges | 65/66B | €19,905 | €20,437 | +€533 | +2.7% |
| Recurring financial charges | 65 | €19,905 | €20,437 | +€533 | +2.7% |
| Profit (loss) for the period before taxes | 9903 | -€44,629 | -€112,104 | -€67,475 | -151% |
| Profit (loss) for the period | 9904 | -€44,629 | -€112,104 | -€67,475 | -151% |
| Profit (loss) for the period to be appropriated | 9905 | -€44,629 | -€112,104 | -€67,475 | -151% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.